Skip to main content

MoneyWorks4Me

Granules India - Quaterly Results

03 Nov 2026 Evaluate
The revenue zoomed 6.30% to Rs. 9478.21 millions for the quarter ended September 2026 as compared to Rs. 8916.13 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 1085.16  millions from Rs. 1206.13 millions ,decline by -10.03%.The company reported a degrowth in operating Profit to 1952.17 millions from 2193.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 9478.21 8916.13 6.30 17496.98 17018.21 2.81 34739.60 30301.63 14.65
Other Income 209.11 78.85 165.20 346.95 210.37 64.92 498.03 406.80 22.43
PBIDT 1952.17 2193.00 -10.98 3404.56 3760.87 -9.47 7738.85 6054.84 27.81
Interest 77.96 166.53 -53.19 174.10 303.26 -42.59 614.38 627.80 -2.14
PBDT 1874.21 2026.47 -7.51 3230.46 3336.01 -3.16 7002.87 5734.54 22.12
Depreciation 413.68 407.41 1.54 804.29 802.48 0.23 1644.73 1462.30 12.48
PBT 1460.53 1619.06 -9.79 2426.17 2533.53 -4.24 5358.14 4272.24 25.42
TAX 375.37 412.93 -9.10 623.55 632.55 -1.42 1351.47 1078.88 25.27
Deferred Tax -26.35 -18.25 44.38 -43.77 -28.55 53.31 -0.08 -19.91 -99.60
PAT 1085.16 1206.13 -10.03 1802.62 1900.98 -5.17 4006.67 3193.36 25.47
Equity 272.78 242.67 12.41 272.78 242.67 12.41 247.80 242.54 2.17
PBIDTM(%) 20.60 24.60 -16.26 19.46 22.10 -11.95 22.28 19.98 11.48
Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..